Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disorders

Neuroscience and Biobehavioral Reviews

Volumn 52, Issue , 2015, Pages 89-104

  Mansur, Rodrigo B ^a,b   Brietzke, Elisa ^b   McIntyre, Roger S ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bipolar disorder; Diabetes mellitus; Major depressive disorder; Metabolic syndrome; Metabolism; Mood disorders; Obesity; RDoC; Research domain criteria; Subtypes

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOBESITY AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; ENDOCANNABINOID; LITHIUM; RIMONABANT; VALPROIC ACID;

ANXIETY DISORDER; BARIATRIC SURGERY; BEHAVIOR MODIFICATION; BIPOLAR DISORDER; BRAIN FUNCTION; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; HERITABILITY; HUMAN; MAJOR DEPRESSION; MEDICAL RESEARCH; MENTAL DISEASE; METABOLIC MOOD SYNDROME; METABOLIC SYNDROME X; METHODOLOGY; MOOD DISORDER; NEUROBIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOMENOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SUICIDAL IDEATION; TREATMENT OUTCOME; VALIDITY; WEIGHT REDUCTION; BRAIN; ENVIRONMENT; GENETICS; METABOLISM; MOOD DISORDERS; RISK FACTOR;

BRAIN; ENVIRONMENT; HUMANS; MOOD DISORDERS; OBESITY; PHENOTYPE; RISK FACTORS;

EID: 84924569218     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.12.017     Document Type: Review

References (360)

1. Abildgaard A., Solskov L., Volke V., Harvey B.H., Lund S., Wegener G. A high-fat diet exacerbates depressive-like behavior in the Flinders Sensitive Line (FSL) rat, a genetic model of depression. Psychoneuroendocrinology 2011, 36(5):623-633.
2. Adam E.K. Transactions among adolescent trait and state emotion and diurnal and momentary cortisol activity in naturalistic settings. Psychoneuroendocrinology 2006, 31(5):664-679.
3. Afari N., Noonan C., Goldberg J., et al. Depression and obesity: do shared genes explain the relationship?. Depress. Anxiety 2010, 27(9):799-806.
4. Ahmad S., Rukh G., Varga T.V., et al. Gene×physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genet. 2013, 9(7):e1003607.
5. Ali S., Stone M.A., Peters J.L., Davies M.J., Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetes Med. 2006, 23(11):1165-1173.
6. Allender S., Rayner M. The burden of overweight and obesity-related ill health in the UK. Obes. Rev. 2007, 8(5):467-473.
7. Altman S., Haeri S., Cohen L.J., et al. Predictors of relapse in bipolar disorder: a review. J. Psychiatr. Pract. 2006, 12(5):269-282.
8. Anand A., Barkay G., Dzemidzic M., et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord. 2011, 13(4):406-413.
9. Antenor-Dorsey J.A., Meyer E., Rutlin J., et al. White matter microstructural integrity in youth with type 1 diabetes. Diabetes 2013, 62(2):581-589.
10. Ashton C.H., Moore P.B. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr. Scand. 2011, 124(4):250-261.
11. Atlantis E., Sullivan T. Changes in cardiovascular disease burden associated with psychopathology in Australian adults 2004-2008. Gen. Hosp. Psychiatry 2012, 34(4):345-351.
12. Baldo B.A., Kelley A.E. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl.) 2007, 191(3):439-459.
13. Barbosa I.G., Rocha N.P., de Miranda A.S., et al. Increased levels of adipokines in bipolar disorder. J. Psychiatr. Res. 2012, 46(3):389-393.
14. Barnard K.D., Skinner T.C., Peveler R. The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabetes Med. 2006, 23(4):445-448.
15. Baskaran A., Cha D.S., Powell A.M., Jalil D., McIntyre R.S. Sex differences in rates of obesity in bipolar disorder: postulated mechanisms. Bipolar Disord. 2014, 16(1):83-92.
16. Baxter A.J., Scott K.M., Ferrari A.J., Norman R.E., Vos T., Whiteford H.A. Challenging the myth of an "epidemic" of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depress. Anxiety 2014.
17. Bell C.G., Walley A.J., Froguel P. The genetics of human obesity. Nat. Rev. Genet. 2005, 6(3):221-234.
18. Bell M.E., Bhargava A., Soriano L., Laugero K., Akana S.F., Dallman M.F. Sucrose intake and corticosterone interact with cold to modulate ingestive behaviour, energy balance, autonomic outflow and neuroendocrine responses during chronic stress. J. Neuroendocrinol. 2002, 14(4):330-342.
19. Benard G., Massa F., Puente N., et al. Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat. Neurosci. 2012, 15(4):558-564.
20. Bennetzen M.F., Wellner N., Ahmed S.S., et al. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss. Int. J. Obes. (Lond.) 2011, 35(11):1377-1384.
21. Bermudez-Silva F.J., Cardinal P., Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J. Psychopharmacol. 2012, 26(1):114-124.
22. Bjornsson H.T., Fallin M.D., Feinberg A.P. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 2004, 20(8):350-358.
23. Blaine B. Does depression cause obesity? A meta-analysis of longitudinal studies of depression and weight control. J. Health Psychol. 2008, 13(8):1190-1197.
24. Blond B.N., Fredericks C.A., Blumberg H.P. Functional neuroanatomy of bipolar disorder: structure, function, and connectivity in an amygdala-anterior paralimbic neural system. Bipolar Disord. 2012, 14(4):340-355.
25. Bluher M., Engeli S., Kloting N., et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 2006, 55(11):3053-3060.
26. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J. Biol. Psychiatry 2010, 11(6):763-773.
27. Bond D.J., Lang D.J., Noronha M.M., et al. The association of elevated body mass index with reduced brain volumes in first-episode mania. Biol. Psychiatry 2011, 70(4):381-387.
28. Boon M.R., Kooijman S., van Dam A.D., et al. Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity. FASEB J. 2014.
29. Bourne C., Aydemir O., Balanza-Martinez V., et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr. Scand. 2013, 128(3):149-162.
30. Bowden C.L., Perlis R.H., Thase M.E., et al. Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD). CNS Neurosci. Ther. 2012, 18(3):243-249.
31. Brady R.O., Cooper A., Jensen J.E., et al. A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Transl. Psychiatry 2012, 2:e160.
32. Brooks S.J., Nilsson E.K., Jacobsson J.A., et al. BDNF polymorphisms are linked to poorer working memory performance, reduced cerebellar and hippocampal volumes and differences in prefrontal cortex in a Swedish elderly population. PLOS ONE 2014, 9(1):e82707.
33. Brown E.S., Varghese F.P., McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biol. Psychiatry 2004, 55(1):1-9.
34. Bruce D.G., Davis W.A., Cetrullo V., Starkstein S.E., Davis T.M. Clinical impact of the temporal relationship between depression and type 2 diabetes: the fremantle diabetes study phase II. PLOS ONE 2013, 8(12):e81254.
35. Buettner R., Scholmerich J., Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007, 15(4):798-808.
36. Burkhalter J., Fiumelli H., Allaman I., Chatton J.Y., Martin J.L. Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons. J. Neurosci. 2003, 23(23):8212-8220.
37. Busch A.M., Whited M.C., Appelhans B.M., et al. Reliable change in depression during behavioral weight loss treatment among women with major depression. Obesity (Silver Spring) 2013, 21(3):E211-E218.
38. Byers A.L., Vittinghoff E., Lui L.Y., et al. Twenty-year depressive trajectories among older women. Arch. Gen. Psychiatry 2012, 69(10):1073-1079.
39. Calkin C., van de Velde C., Ruzickova M., et al. Can body mass index help predict outcome in patients with bipolar disorder?. Bipolar Disord. 2009, 11(6):650-656.
40. Camardese G., Di Giuda D., Di Nicola M., et al. Imaging studies on dopamine transporter and depression: a review of literature and suggestions for future research. J. Psychiatr. Res. 2014, 51:7-18.
41. Canetti L., Bachar E., Berry E.M. Food and emotion. Behav. Process. 2002, 60(2):157-164.
42. Carr C.P., Martins C.M., Stingel A.M., Lemgruber V.B., Juruena M.F. The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes. J. Nerv. Mental Dis. 2013, 201(12):1007-1020.
43. Cervantes P., Gelber S., Kin F.N., Nair V.N., Schwartz G. Circadian secretion of cortisol in bipolar disorder. J. Psychiatry Neurosci. 2001, 26(5):411-416.
44. Chalder M., Wiles N.J., Campbell J., et al. A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial. Health Technol. Assess. 2012, 16(10):1-164. iii-iv.
45. Chang H.H., Yen S.T. Association between obesity and depression: evidence from a longitudinal sample of the elderly in Taiwan. Aging Mental Health 2012, 16(2):173-180.
46. Chang T.T., Yeh T.L., Chiu N.T., et al. Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1. Bipolar Disord. 2010, 12(1):102-106.
47. Chaput J.P., Arguin H., Gagnon C., Tremblay A. Increase in depression symptoms with weight loss: association with glucose homeostasis and thyroid function. Appl. Physiol. Nutr. Metab. 2008, 33(1):86-92.
48. Cheng G., Huang C., Deng H., Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern. Med. J. 2012, 42(5):484-491.
49. Choi J., Joseph L., Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes. Rev. 2013, 14(3):232-244.
50. Chou K.L., Yu K.M. Atypical depressive symptoms and obesity in a national sample of older adults with major depressive disorder. Depress. Anxiety 2013, 30(6):574-579.
51. Christopoulou F.D., Kiortsis D.N. An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity. J. Clin. Pharm. Ther. 2011, 36(1):10-18.
52. Chu W.J., Delbello M.P., Jarvis K.B., et al. Magnetic resonance spectroscopy imaging of lactate in patients with bipolar disorder. Psychiatry Res. 2013, 213(3):230-234.
53. Chuang J.C., Cui H., Mason B.L., et al. Chronic social defeat stress disrupts regulation of lipid synthesis. J. Lipid Res. 2010, 51(6):1344-1353.
54. Cizza G., Ronsaville D.S., Kleitz H., et al. Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study. PLoS ONE 2012, 7(1):e28912.
55. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 2011, 29(3):311-324.
56. Cole J.H., Boyle C.P., Simmons A., et al. Body mass index, but not FTO genotype or major depressive disorder, influences brain structure. Neuroscience 2013, 252:109-117.
57. Correll C.U., Penzner J.B., Lencz T., et al. Early identification and high-risk strategies for bipolar disorder. Bipolar Disord. 2007, 9(4):324-338.
58. Costa e Silva J.A. Personalized medicine in psychiatry: new technologies and approaches. Metabolism 2013, 62(Suppl. 1):S40-S44.
59. Cota D., Tschop M.H., Horvath T.L., Levine A.S. Cannabinoids, opioids and eating behavior: the molecular face of hedonism?. Brain Res. Rev. 2006, 51(1):85-107.
60. Cowansage K.K., LeDoux J.E., Monfils M.H. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr. Mol. Pharmacol. 2010, 3(1):12-29.
61. Czepielewski L., Daruy-Filho L., Brietzke E., Grassi-Oliveira R. Bipolar disorder and metabolic syndrome: a systematic review. Rev. Bras. Psiquiatr. 2013, 35(1):88-93.
62. D'Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur. J. Pharmacol. 2000, 405(1-3):365-373.
63. Daban C., Vieta E., Mackin P., Young A.H. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr. Clin. N. Am. 2005, 28(2):469-480.
64. Dave D.M., Tennant J., Colman G. Isolating the effect of major depression on obesity: role of selection bias. J. Mental Health Policy Econ. 2011, 14(4):165-186.
65. de Groot M., Anderson R., Freedland K.E., Clouse R.E., Lustman P.J. Association of depression and diabetes complications: a meta-analysis. Psychosomal Med. 2001, 63(4):619-630.
66. Denis G.V., Obin M.S. 'Metabolically healthy obesity': origins and implications. Mol. Asp. Med. 2013, 34(1):59-70.
67. Despres J.P. Health consequences of visceral obesity. Ann. Med. 2001, 33(8):534-541.
68. Devaux M., Sassi F. Social inequalities in obesity and overweight in 11 OECD countries. Eur. J. Public Health 2013, 23(3):464-469.
69. Di Marzo V., Cote M., Matias I., et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 2009, 52(2):213-217.
70. Di Marzo V., Despres J.P. CB1 antagonists for obesity - what lessons have we learned from rimonabant?. Nat. Rev. Endocrinol. 2009, 5(11):633-638.
71. Diener C., Kuehner C., Brusniak W., Ubl B., Wessa M., Flor H. A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. Neuroimage 2012, 61(3):677-685.
72. Dillon D.G., Rosso I.M., Pechtel P., Killgore W.D., Rauch S.L., Pizzagalli D.A. Peril and pleasure: an RDoC-inspired examination of threat responses and reward processing in anxiety and depression. Depress. Anxiety 2014, 31(3):233-249.
73. Dincheva I., Glatt C.E., Lee F.S. Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics. Neuroscientist 2012, 18(5):439-451.
74. Dlugos A., Childs E., Stuhr K.L., Hillard C.J., de Wit H. Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology 2012, 37(11):2416-2427.
75. Dong Q., Liu J.J., Zheng R.Z., et al. Obesity and depressive symptoms in the elderly: a survey in the rural area of Chizhou, Anhui province. Int. J. Geriatr. Psychiatry 2013, 28(3):227-232.
76. Dowlati Y., Herrmann N., Swardfager W., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67(5):446-457.
77. Elder C.R., Gullion C.M., Funk K.L., Debar L.L., Lindberg N.M., Stevens V.J. Impact of sleep, screen time, depression and stress on weight change in the intensive weight loss phase of the LIFE study. Int. J. Obes. (Lond.) 2012, 36(1):86-92.
78. Everson S.A., Maty S.C., Lynch J.W., Kaplan G.A. Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J. Psychosomal Res. 2002, 53(4):891-895.
79. Fabricatore A.N., Wadden T.A., Higginbotham A.J., et al. Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis. Int. J. Obes. (Lond.) 2011, 35(11):1363-1376.
80. Fagiolini A., Frank E., Scott J.A., Turkin S., Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005, 7(5):424-430.
81. Fernandes B.S., Gama C.S., Cereser K.M., et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J. Psychiatr. Res. 2011, 45(8):995-1004.
82. Ferrannini E., Natali A., Bell P., Cavallo-Perin P., Lalic N., Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J. Clin. Invest. 1997, 100(5):1166-1173.
83. Ferrannini E., Natali A., Camastra S., et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 2013, 62(5):1730-1737.
84. Fesinmeyer M.D., North K.E., Ritchie M.D., et al. Genetic risk factors for BMI and obesity in an ethnically diverse population: results from the population architecture using genomics and epidemiology (PAGE) study. Obesity (Silver Spring) 2013, 21(4):835-846.
85. Field A.E., Camargo C.A., Ogino S. The merits of subtyping obesity: one size does not fit all. JAMA 2013, 310(20):2147-2148.
86. Finkelstein E.A., Brown D.S., Wrage L.A., Allaire B.T., Hoerger T.J. Individual and aggregate years-of-life-lost associated with overweight and obesity. Obesity (Silver Spring) 2010, 18(2):333-339.
87. Finkelstein E.A., Trogdon J.G., Cohen J.W., Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff. (Millwood) 2009, 28(5):w822-w831.
88. Flegal K.M., Kit B.K., Orpana H., Graubard B.I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013, 309(1):71-82.
89. Flint J., Kendler K.S. The genetics of major depression. Neuron 2014, 81(3):484-503.
90. Forde N.J., Ronan L., Suckling J., et al. Structural neuroimaging correlates of allelic variation of the BDNF val66met polymorphism. Neuroimage 2014, 90:280-289.
91. Fuemmeler B.F., Agurs-Collins T., McClernon F.J., Kollins S.H., Garrett M.E., Ashley-Koch A.E. Interactions between genotype and depressive symptoms on obesity. Behav. Genet. 2009, 39(3):296-305.
92. Galler J.R., Bryce C.P., Waber D., et al. Early childhood malnutrition predicts depressive symptoms at ages 11-17. J. Child Psychol. Psychiatry 2010, 51(7):789-798.
93. Garcia-Garcia I., Jurado M.A., Garolera M., et al. Functional connectivity in obesity during reward processing. Neuroimage 2012, 66C:232-239.
94. Gardner A., Boles R.G. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(3):730-743.
95. Gault V.A., Porter W.D., Flatt P.R., Holscher C. Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet. Int. J. Obes. (Lond.) 2010, 34(8):1341-1344.
96. Gazdzinski S., Kornak J., Weiner M.W., Meyerhoff D.J. Body mass index and magnetic resonance markers of brain integrity in adults. Ann. Neurol. 2008, 63(5):652-657.
97. Gazdzinski S., Millin R., Kaiser L.G., et al. BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy study. Obesity (Silver Spring) 2010, 18(4):743-748.
98. Geissler A., Frund R., Scholmerich J., Feuerbach S., Zietz B. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp. Clin. Endocrinol. Diabetes 2003, 111(7):421-427.
99. Glaus J., Vandeleur C., Gholam-Rezaee M., et al. Atypical depression and alcohol misuse are related to the cardiovascular risk in the general population. Acta Psychiatr. Scand. 2012.
100. Gloy V.L., Briel M., Bhatt D.L., et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013, 347:f5934.
101. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 2008, 359(1):61-73.
102. Gobbi G., Bambico F.R., Mangieri R., et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(51):18620-18625.
103. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 2002, 7(3):254-275.
104. Gold S.M., Dziobek I., Sweat V., et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007, 50(4):711-719.
105. Golden S.H., Lazo M., Carnethon M., et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008, 299(23):2751-2759.
106. Goldstein B.I., Liu S.M., Schaffer A., Sala R., Blanco C. Obesity and the three-year longitudinal course of bipolar disorder. Bipolar Disord. 2013, 15(3):284-293.
107. Goldstein B.I., Liu S.M., Zivkovic N., Schaffer A., Chien L.C., Blanco C. The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord. 2011, 13(4):387-395.
108. Gonzalez de Castro D., Clarke P.A., Al-Lazikani B., Workman P. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. Clin. Pharmacol. Ther. 2013, 93(3):252-259.
109. Goodman E., Whitaker R.C. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002, 110(3):497-504.
110. Grigoriadis S., VonderPorten E.H., Mamisashvili L., et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 2013, 74(4):e321-e341.
111. Guenard F., Deshaies Y., Cianflone K., Kral J.G., Marceau P., Vohl M.C. Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(28):11439-11444.
112. Guenard F., Tchernof A., Deshaies Y., et al. Methylation and expression of immune and inflammatory genes in the offspring of bariatric bypass surgery patients. J. Obes. 2013, 492170.
113. Guha P., Bhowmick K., Mazumder P., Ghosal M., Chakraborty I., Burman P. Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder. Indian J. Clin. Biochem. 2014, 29(1):51-56.
114. Gunstad J., Lhotsky A., Wendell C.R., Ferrucci L., Zonderman A.B. Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. Neuroepidemiology 2010, 34(4):222-229.
115. Gunstad J., Paul R.H., Cohen R.A., Tate D.F., Spitznagel M.B., Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr. Psychiatry 2007, 48(1):57-61.
116. Gunstad J., Paul R.H., Spitznagel M.B., et al. Exposure to early life trauma is associated with adult obesity. Psychiatry Res. 2006, 142(1):31-37.
117. Haack M., Hinze-Selch D., Fenzel T., et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J. Psychiatr. Res. 1999, 33(5):407-418.
118. Hajek T., Calkin C., Blagdon R., Slaney C., Alda M. Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders. Biol. Psychiatry 2013.
119. Hamer M., Batty G.D., Kivimaki M. Haemoglobin A1c, fasting glucose and future risk of elevated depressive symptoms over 2 years of follow-up in the English Longitudinal Study of Ageing. Psychol. Med. 2011, 41(9):1889-1896.
120. Hamer M., Batty G.D., Kivimaki M. Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing. Mol. Psychiatry 2012, 17(9):940-945.
121. Harald B., Gordon P. Meta-review of depressive subtyping models. J. Affect. Disord. 2012, 139(2):126-140.
122. Hebebrand J., Friedel S., Schauble N., Geller F., Hinney A. Perspectives: molecular genetic research in human obesity. Obes. Rev. 2003, 4(3):139-146.
123. Hickman R.J., Khambaty T., Stewart J.C. C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. J. Behav. Med. 2013.
124. Hill M.N., Gorzalka B.B. The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol. Disord. Drug Targets 2009, 8(6):451-458.
125. Hill M.N., Ho W.S., Hillard C.J., Gorzalka B.B. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. J. Neural. Transm. 2008, 115(12):1673-1679.
126. Hill M.N., McEwen B.S. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(5):791-797.
127. Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J. Neurosci. 2010, 30(45):14980-14986.
128. Hill M.N., Tasker J.G. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 2012, 204:5-16.
129. Hitze B., Hubold C., van Dyken R., et al. How the selfish brain organizes its supply and demand. Front. Neuroenergetics 2010, 2:7.
130. Ho B.C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch. Gen. Psychiatry 2006, 63(7):731-740.
131. Hong C.J., Liou Y.J., Tsai S.J. Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res. Bull. 2011, 86(5-6):287-297.
132. Horesh N., Apter A., Zalsman G. Timing, quantity and quality of stressful life events in childhood and preceding the first episode of bipolar disorder. J. Affect. Disord. 2011, 134(1-3):434-437.
133. Horesh N., Iancu I. A comparison of life events in patients with unipolar disorder or bipolar disorder and controls. Compr. Psychiatry 2010, 51(2):157-164.
134. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein IL-1, and IL-6: a meta-analysis. Psychosomal Med. 2009, 71(2):171-186.
135. Hu H., Xu Y., Liu C., Zhao H., Zhang H., Wang L. Changes in behavior and in brain glucose metabolism in rats after nine weeks on a high fat diet: a randomized controlled trial. Shanghai Arch. Psychiatry 2014, 26(3):129-137.
136. Hussain S.S., Bloom S.R. The regulation of food intake by the gut-brain axis: implications for obesity. Int. J. Obes. (Lond.) 2013, 37(5):625-633.
137. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes. Res. 2005, 13(6):1116-1122.
138. Iio W., Tokutake Y., Koike H., et al. Effects of chronic mild food restriction on behavior and the hypothalamic malonyl-CoA signaling pathway. Anim. Sci. J. 2014.
139. Iio W., Tokutake Y., Matsukawa N., Tsukahara T., Chohnan S., Toyoda A. Anorexic behavior and elevation of hypothalamic malonyl-CoA in socially defeated rats. Biochem. Biophys. Res. Commun. 2012, 421(2):301-304.
140. Insel T.R. The NIMH Research Domain Criteria (RDoC) project: precision medicine for psychiatry. Am. J. Psychiatry 2014, 171(4):395-397.
141. Iosifescu D.V., Renshaw P.E. 31P-magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression?. Harv. Rev. Psychiatry 2003, 11(2):51-63.
142. Jackson M.B., Ahima R.S. Neuroendocrine and metabolic effects of adipocyte-derived hormones. Clin. Sci. (Lond.) 2006, 110(2):143-152.
143. Jauch-Chara K., Oltmanns K.M. Obesity - a neuropsychological disease? Systematic review and neuropsychological model. Prog. Neurobiol. 2014, 114:84-101.
144. Jialin W., Yi Z., Weijie Y. Relationship between body mass index and mortality in hemodialysis patients: a meta-analysis. Nephron Clin. Pract. 2012, 121(3-4):c102-c111.
145. Jokela M., Elovainio M., Keltikangas-Jarvinen L., et al. Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score. Genes Brain Behav. 2012.
146. Jokela M., Hamer M., Singh-Manoux A., Batty G.D., Kivimaki M. Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies. Mol. Psychiatry 2013.
147. Jones A., McMillan M.R., Jones R.W., et al. Adiposity is associated with blunted cardiovascular, neuroendocrine and cognitive responses to acute mental stress. PLoS ONE 2012, 7(6):e39143.
148. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444(7121):840-846.
149. Kan C., Silva N., Golden S.H., et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013, 36(2):480-489.
150. Karatsoreos I.N., Thaler J.P., Borgland S.L., Champagne F.A., Hurd Y.L., Hill M.N. Food for thought: hormonal, experiential, and neural influences on feeding and obesity. J. Neurosci. 2013, 33(45):17610-17616.
151. Karelis A.D., Faraj M., Bastard J.P., et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 2005, 90(7):4145-4150.
152. Kelly T., Yang W., Chen C.S., Reynolds K., He J. Global burden of obesity in 2005 and projections to 2030. Int. J. Obes. (Lond.) 2008, 32(9):1431-1437.
153. Kemp D.E., Gao K., Chan P.K., Ganocy S.J., Findling R.L., Calabrese J.R. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord. 2010, 12(4):404-413.
154. Kemp D.E., Ismail-Beigi F., Ganocy S.J., et al. Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. J. Affect. Disord. 2012, 136(3):1164-1173.
155. Kemp D.E., Sylvia L.G., Calabrese J.R., et al. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr. Scand. 2014, 129(1):24-34.
156. Kendler K.S., Aggen S.H., Neale M.C. Evidence for multiple genetic factors underlying DSM-IV criteria for major depression. JAMA Psychiatry 2013, 70(6):599-607.
157. Kendler K.S., Gatz M., Gardner C.O., Pedersen N.L. A Swedish national twin study of lifetime major depression. Am. J. Psychiatry 2006, 163(1):109-114.
158. Keranen A.M., Rasinaho E., Hakko H., Savolainen M., Lindeman S. Eating behavior in obese and overweight persons with and without anhedonia. Appetite 2010, 55(3):726-729.
159. Kerner B. Genetics of bipolar disorder. Appl. Clin. Genet. 2014, 7:33-42.
160. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62(6):593-602.
161. Khan A., Schwartz K.A., Kolts R.L., Brown W.A. BMI, sex, and antidepressant response. J. Affect. Disord. 2007, 99(1-3):101-106.
162. Kim E.Y., Miklowitz D.J., Biuckians A., Mullen K. Life stress and the course of early-onset bipolar disorder. J. Affect. Disord. 2007, 99(1-3):37-44.
163. Kim M., Bae S., Lim K.M. Impact of high fat diet-induced obesity on the plasma levels of monoamine neurotransmitters in C57BL/6 mice. Biomol. Ther. (Seoul) 2013, 21(6):476-480.
164. Kloiber S., Ising M., Reppermund S., et al. Overweight and obesity affect treatment response in major depression. Biol. Psychiatry 2007, 62(4):321-326.
165. Koethe D., Llenos I.C., Dulay J.R., et al. Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J. Neural Transm. 2007, 114(8):1055-1063.
166. Kraguljac N.V., Reid M., White D., et al. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res. 2012, 203(2-3):111-125.
167. Kramer C.K., Zinman B., Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann. Intern. Med. 2013, 159(11):758-769.
168. Kubera B., Hubold C., Zug S., et al. The brain's supply and demand in obesity. Front. Neuroenergetics 2012, 4:4.
169. Kullmann S., Heni M., Veit R., et al. The obese brain: association of body mass index and insulin sensitivity with resting state network functional connectivity. Hum. Brain Mapp. 2012, 33(5):1052-1061.
170. Kuswanto C.N., Sum M.Y., Yang G.L., Nowinski W.L., McIntyre R.S., Sim K. Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania. Psychol. Med. 2014, 44(3):533-541.
171. Kyrou I., Chrousos G.P., Tsigos C. Stress, visceral obesity, and metabolic complications. Ann. N. Y. Acad. Sci. 2006, 1083:77-110.
172. Lai J.S., Hiles S., Bisquera A., Hure A.J., McEvoy M., Attia J. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am. J. Clin. Nutr. 2014, 99(1):181-197.
173. Lamers F., de Jonge P., Nolen W.A., et al. Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA). J. Clin. Psychiatry 2010, 71(12):1582-1589.
174. Lamers F., Vogelzangs N., Merikangas K.R., de Jonge P., Beekman A.T., Penninx B.W. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol. Psychiatry 2013, 18(6):692-699.
175. Le Foll B., Gorelick D.A., Goldberg S.R. The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology (Berl.) 2009, 205(1):171-174.
176. Le T.K., Curtis B., Kahle-Wrobleski K., Johnston J., Haldane D., Melfi C. Treatment patterns and resource use among patients with comorbid diabetes mellitus and major depressive disorder. J. Med. Econ. 2011, 14(4):440-447.
177. Lee C., Tsenkova V., Carr D. Childhood trauma and metabolic syndrome in men and women. Soc. Sci. Med. 2014, 105:122-130.
178. Lee I.T., Fu C.P., Lee W.J., et al. Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study. Diabetol. Metab. Syndr. 2014, 6(1):18.
179. Lee R.S., Hermens D.F., Porter M.A., Redoblado-Hodge M.A. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. J. Affect. Disord. 2012, 140(2):113-124.
180. Legenbauer T., De Zwaan M., Benecke A., Muhlhans B., Petrak F., Herpertz S. Depression and anxiety: their predictive function for weight loss in obese individuals. Obes. Facts 2009, 2(4):227-234.
181. Legenbauer T., Petrak F., de Zwaan M., Herpertz S. Influence of depressive and eating disorders on short- and long-term course of weight after surgical and nonsurgical weight loss treatment. Compr. Psychiatry 2011, 52(3):301-311.
182. Levitan R.D., Davis C., Kaplan A.S., Arenovich T., Phillips D.I., Ravindran A.V. Obesity comorbidity in unipolar major depressive disorder: refining the core phenotype. J. Clin. Psychiatry 2012, 73(8):1119-1124.
183. Liao X., Lochhead P., Nishihara R., et al. Aspirin use, tumor PIK3CA mutation, colorectal-cancer survival. N. Engl. J. Med. 2012, 367(17):1596-1606.
184. Liao Y., Huang X., Wu Q., et al. Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J. Psychiatry Neurosci. 2013, 38(1):49-56.
185. Lin E.J., Sun M., Choi E.Y., Magee D., Stets C.W., During M.J. Social overcrowding as a chronic stress model that increases adiposity in mice. Psychoneuroendocrinology 2014, 51C:318-330.
186. Lin F., Weng S., Xie B., Wu G., Lei H. Abnormal frontal cortex white matter connections in bipolar disorder: a DTI tractography study. J. Affect. Disord. 2011, 131(1-3):299-306.
187. Linde J.A., Simon G.E., Ludman E.J., et al. A randomized controlled trial of behavioral weight loss treatment versus combined weight loss/depression treatment among women with comorbid obesity and depression. Ann. Behav. Med. 2011, 41(1):119-130.
188. Lopresti A.L., Hood S.D., Drummond P.D. A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J. Affect. Disord. 2013, 148(1):12-27.
189. Lu X.Y. The leptin hypothesis of depression: a potential link between mood disorders and obesity?. Curr. Opin. Pharmacol. 2007, 7(6):648-652.
190. Lu Y., Hajifathalian K., Ezzati M., Woodward M., Rimm E.B., Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014, 383(9921):970-983.
191. Ludescher B., Machann J., Eschweiler G.W., et al. Active depression is associated with regional adiposity in the upper abdomen and the neck. Int. J. Psychiatry Med. 2011, 41(3):271-280.
192. Luppino F.S., de Wit L.M., Bouvy P.F., et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 2010, 67(3):220-229.
193. Lustman P.J., Anderson R.J., Freedland K.E., de Groot M., Carney R.M., Clouse R.E. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23(7):934-942.
194. Lyoo I.K., Yoon S., Kim T.S., et al. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. Am. J. Psychiatry 2012, 169(9):937-945.
195. Manji H., Kato T., Di Prospero N.A., et al. Impaired mitochondrial function in psychiatric disorders. Nat. Rev. Neurosci. 2012, 13(5):293-307.
196. Mann-Wrobel M.C., Carreno J.T., Dickinson D. Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord. 2011, 13(4):334-342.
197. Marazziti D., Baroni S., Picchetti M., et al. Mitochondrial alterations and neuropsychiatric disorders. Curr. Med. Chem. 2011, 18(30):4715-4721.
198. Marijnissen R.M., Bus B.A., Holewijn S., et al. Depressive symptom clusters are differentially associated with general and visceral obesity. J. Am. Geriatr. Soc. 2011, 59(1):67-72.
199. Markham A., Cameron I., Bains R., et al. Brain-derived neurotrophic factor-mediated effects on mitochondrial respiratory coupling and neuroprotection share the same molecular signalling pathways. Eur. J. Neurosci. 2012, 35(3):366-374.
200. Marosi K., Mattson M.P. BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol. Metab. 2014, 25(2):89-98.
201. Marques-Vidal P., Pecoud A., Hayoz D., et al. Prevalence of normal weight obesity in Switzerland: effect of various definitions. Eur. J. Nutr. 2008, 47(5):251-257.
202. Mather A.A., Cox B.J., Enns M.W., Sareen J. Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample. J. Psychosomal Res. 2009, 66(4):277-285.
203. Mathers C.D., Lopez A.D., Murray C.J.L. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001 2006.
204. Matias I., Gatta-Cherifi B., Tabarin A., et al. Endocannabinoids measurement in human saliva as potential biomarker of obesity. PLoS ONE 2012, 7(7):e42399.
205. McCrimmon R.J., Ryan C.M., Frier B.M. Diabetes and cognitive dysfunction. Lancet 2012, 379(9833):2291-2299.
206. McIntyre R.S., Danilewitz M., Liauw S.S., et al. Bipolar disorder and metabolic syndrome: an international perspective. J. Affect. Disord. 2010, 126(3):366-387.
207. McIntyre R.S., Muzina D.J., Kemp D.E., et al. Bipolar disorder and suicide: research synthesis and clinical translation. Curr. Psychiatry Rep. 2008, 10(1):66-72.
208. McIntyre R.S., Soczynska J.K., Konarski J.Z., et al. Should depressive syndromes be reclassified as "metabolic syndrome type II"?. Ann. Clin. Psychiatry 2007, 19(4):257-264.
209. McIntyre R.S., Soczynska J.K., Woldeyohannes H.O., et al. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder. Bipolar Disord. 2012, 14(7):697-706.
210. Midei A.J., Matthews K.A., Bromberger J.T. Childhood abuse is associated with adiposity in midlife women: possible pathways through trait anger and reproductive hormones. Psychosomal Med. 2010, 72(2):215-223.
211. Midei A.J., Matthews K.A., Chang Y.F., Bromberger J.T. Childhood physical abuse is associated with incident metabolic syndrome in mid-life women. Health Psychol. 2013, 32(2):121-127.
212. Milaneschi Y., Simonsick E.M., Vogelzangs N., et al. Leptin, abdominal obesity, and onset of depression in older men and women. J. Clin. Psychiatry 2012, 73(9):1205-1211.
213. Milaneschi Y., Sutin A.R., Terracciano A., et al. The association between leptin and depressive symptoms is modulated by abdominal adiposity. Psychoneuroendocrinology 2014, 42:1-10.
214. Mitchell P.B., Morris M.J. Depression and anxiety with rimonabant. Lancet 2007, 370(9600):1671-1672.
215. Moore T.R. Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome. Am. J. Obstet. Gynecol. 2010, 202(6):643-649.
216. Moreira F.A., Kaiser N., Monory K., Lutz B. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 2008, 54(1):141-150.
217. Morkedal B., Vatten L.J., Romundstad P.R., Laugsand L.E., Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway. J. Am. Coll. Cardiol. 2014, 63(11):1071-1078.
218. Morris S.E., Cuthbert B.N. Research domain criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin. Neurosci. 2012, 14(1):29-37.
219. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 2013, 18(5):595-606.
220. Mujica-Parodi L.R., Renelique R., Taylor M.K. Higher body fat percentage is associated with increased cortisol reactivity and impaired cognitive resilience in response to acute emotional stress. Int. J. Obes. (Lond.) 2009, 33(1):157-165.
221. Munkholm K., Vinberg M., Vedel Kessing L. Cytokines in bipolar disorder: a systematic review and meta-analysis. J. Affect. Disord. 2013, 144(1-2):16-27.
222. Musen G., Jacobson A.M., Bolo N.R., et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 2012, 61(9):2375-2379.
223. Nanni V., Uher R., Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am. J. Psychiatry 2012, 169(2):141-151.
224. Naukkarinen J., Rissanen A., Kaprio J., Pietilainen K.H. Causes and consequences of obesity: the contribution of recent twin studies. Int. J. Obes. (Lond.) 2012, 36(8):1017-1024.
225. Nierenberg A.A., Husain M.M., Trivedi M.H., et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol. Med. 2010, 40(1):41-50.
226. Nomura Y., Wickramaratne P.J., Pilowsky D.J., et al. Low birth weight and risk of affective disorders and selected medical illness in offspring at high and low risk for depression. Compr. Psychiatry 2007, 48(5):470-478.
227. OECD Health at a Glance 2013: OECD Indicators 2013, OECD Publishing. 10.1787/health_glance-2013-en.
228. Ohsiek S., Williams M. Psychological factors influencing weight loss maintenance: an integrative literature review. J. Am. Acad. Nurse Pract. 2011, 23(11):592-601.
229. Oliver G., Wardle J., Gibson E.L. Stress and food choice: a laboratory study. Psychosomal Med. 2000, 62(6):853-865.
230. Oliveros E., Somers V.K., Sochor O., Goel K., Lopez-Jimenez F. The concept of normal weight obesity. Prog. Cardiovasc. Dis. 2014, 56(4):426-433.
231. Oreopoulos A., Padwal R., Kalantar-Zadeh K., Fonarow G.C., Norris C.M., McAlister F.A. Body mass index and mortality in heart failure: a meta-analysis. Am. Heart J. 2008, 156(1):13-22.
232. Oskooilar N., Wilcox C.S., Tong M.L., Grosz D.E. Body mass index and response to antidepressants in depressed research subjects. J. Clin. Psychiatry 2009, 70(11):1609-1610.
233. Overstreet D.H., Friedman E., Mathe A.A., Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 2005, 29(4-5):739-759.
234. Ownby R.L., Crocco E., Acevedo A., John V., Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 2006, 63(5):530-538.
235. Ozomaro U., Wahlestedt C., Nemeroff C.B. Personalized medicine in psychiatry: problems and promises. BMC Med. 2013, 11:132.
236. Padwal R., McAlister F.A., McMurray J.J., et al. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int. J. Obes. (Lond.) 2013.
237. Pagoto S., Schneider K.L., Whited M.C., et al. Randomized controlled trial of behavioral treatment for comorbid obesity and depression in women: the Be Active Trial. Int. J. Obes. (Lond.) 2013, 37(11):1427-1434.
238. Pan A., Keum N., Okereke O.I., et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012, 35(5):1171-1180.
239. Papakostas G.I., Petersen T., Iosifescu D.V., et al. Obesity among outpatients with major depressive disorder. Int. J. Neuropsychopharmacol. 2005, 8(1):59-63.
240. Pasquali R. The hypothalamic-pituitary-adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects. Ann. N. Y. Acad. Sci. 2012, 1264:20-35.
241. Pasquali R., Vicennati V., Cacciari M., Pagotto U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann. N. Y. Acad. Sci. 2006, 1083:111-128.
242. Patterson Z.R., Khazall R., Mackay H., Anisman H., Abizaid A. Central ghrelin signaling mediates the metabolic response of C57BL/6 male mice to chronic social defeat stress. Endocrinology 2013, 154(3):1080-1091.
243. Pawlby S., Hay D.F., Sharp D., Waters C.S., O'Keane V. Antenatal depression predicts depression in adolescent offspring: prospective longitudinal community-based study. J. Affect. Disord. 2009, 113(3):236-243.
244. Pearson R.M., Evans J., Kounali D., et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry 2013, 70(12):1312-1319.
245. Pecoraro N., Reyes F., Gomez F., Bhargava A., Dallman M.F. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 2004, 145(8):3754-3762.
246. Perala J., Suvisaari J., Saarni S.I., et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 2007, 64(1):19-28.
247. Pereira D.S., de Queiroz B.Z., Miranda A.S., et al. Effects of physical exercise on plasma levels of brain-derived neurotrophic factor and depressive symptoms in elderly women - a randomized clinical trial. Arch. Phys. Med. Rehabil. 2013, 94(8):1443-1450.
248. Pereira T.S., Silva A.A., Alves M.T., et al. Perinatal and early life factors associated with symptoms of depression in Brazilian children. BMC Public Health 2012, 12:605.
249. Perlis R.H., Ostacher M.J., Patel J.K., et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am. J. Psychiatry 2006, 163(2):217-224.
250. Pervanidou P., Chrousos G.P. Metabolic consequences of stress during childhood and adolescence. Metabolism 2012, 61(5):611-619.
251. Petrovich G.D., Holland P.C., Gallagher M. Amygdalar and prefrontal pathways to the lateral hypothalamus are activated by a learned cue that stimulates eating. J. Neurosci. 2005, 25(36):8295-8302.
252. Pfaffenseller B., Fries G.R., Wollenhaupt-Aguiar B., et al. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev. Neurother. 2013, 13(7):827-842.
253. Phillips M.L., Swartz H.A. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am. J. Psychiatry 2014.
254. Pintana H., Apaijai N., Chattipakorn N., Chattipakorn S.C. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. J. Endocrinol. 2013, 218(1):1-11.
255. Pipatpiboon N., Pintana H., Pratchayasakul W., Chattipakorn N., Chattipakorn S.C. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Eur. J. Neurosci. 2013, 37(5):839-849.
256. Porter D.W., Kerr B.D., Flatt P.R., Holscher C., Gault V.A. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance. Diabetes Obes. Metab. 2010, 12(10):891-899.
257. Poston L. Maternal obesity, gestational weight gain and diet as determinants of offspring long term health. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26(5):627-639.
258. Primeau V., Coderre L., Karelis A.D., et al. Characterizing the profile of obese patients who are metabolically healthy. Int. J. Obes. (Lond.) 2011, 35(7):971-981.
259. Raisanen S., Lehto S.M., Nielsen H.S., Gissler M., Kramer M.R., Heinonen S. Risk factors for and perinatal outcomes of major depression during pregnancy: a population-based analysis during 2002-2010 in Finland. BMJ Open 2014, 4(11):e004883.
260. Raison C.L., Rutherford R.E., Woolwine B.J., et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013, 70(1):31-41.
261. Reijmer Y.D., Brundel M., de Bresser J., Kappelle L.J., Leemans A., Biessels G.J. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care 2013, 36(1):137-144.
262. Reijmer Y.D., Leemans A., Brundel M., Kappelle L.J., Biessels G.J. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes 2013.
263. Rivera M., Cohen-Woods S., Kapur K., et al. Depressive disorder moderates the effect of the FTO gene on body mass index. Mol. Psychiatry 2012, 17(6):604-611.
264. Rotella F., Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J. Clin. Psychiatry 2013, 74(1):31-37.
265. Rotella F., Mannucci E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res. Clin. Pract. 2013, 99(2):98-104.
266. Russo S.J., Nestler E.J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 2013, 14(9):609-625.
267. Ruttle P.L., Klein M.H., Slattery M.J., Kalin N.H., Armstrong J.M., Essex M.J. Adolescent adrenocortical activity and adiposity: differences by sex and exposure to early maternal depression. Psychoneuroendocrinology 2014, 47:68-77.
268. Ruzickova M., Slaney C., Garnham J., Alda M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can. J. Psychiatry 2003, 48(7):458-461.
269. Sahin I., Alkan A., Keskin L., et al. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J. Diabetes Complicat. 2008, 22(4):254-260.
270. Samaan Z., Anand S.S., Zhang X., et al. The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Mol. Psychiatry 2013, 18(12):1281-1286.
271. Sanchez-Villegas A., Field A.E., O'Reilly E.J., et al. Perceived and actual obesity in childhood and adolescence and risk of adult depression. J. Epidemiol. Community Health 2012.
272. Sanhueza C., Ryan L., Foxcroft D.R. Diet and the risk of unipolar depression in adults: systematic review of cohort studies. J. Hum. Nutr. Diet 2013, 26(1):56-70.
273. Sassi F., Devaux M., Church J. Education and Obesity in Four OECD Countries. OECD Health Working Paper No. 46 2009, OECD Publishing, Paris. 10.1787/5km4psmtn8zx-en.
274. Schmoller A., Hass T., Strugovshchikova O., et al. Evidence for a relationship between body mass and energy metabolism in the human brain. J. Cereb. Blood Flow Metab. 2010, 30(7):1403-1410.
275. Schulkin J. Allostasis: a neural behavioral perspective. Horm. Behav. 2003, 43(1):21-27. (discussion 28-30).
276. Schulz L.C. The Dutch Hunger Winter and the developmental origins of health and disease. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(39):16757-16758.
277. Schwartz E., Mobbs C.V. Hypothalamic BDNF and obesity: found in translation. Nat. Med. 2012, 18(4):496-497.
278. Sepanjnia K., Modabbernia A., Ashrafi M., Modabbernia M.J., Akhondzadeh S. Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial. Neuropsychopharmacology 2012, 37(9):2093-2100.
279. Sharma A.N., Elased K.M., Garrett T.L., Lucot J.B. Neurobehavioral deficits in db/db diabetic mice. Physiol. Behav. 2010, 101(3):381-388.
280. Sharma S., Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int. J. Obes. (Lond.) 2013, 37(3):382-389.
281. Shugart Y.Y., Chen L., Day I.N., et al. Two British women studies replicated the association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) and BMI. Eur. J. Hum. Genet. 2009, 17(8):1050-1055.
282. Sicras A., Rejas J., Navarro R., Serrat J., Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord. 2008, 10(5):607-616.
283. Siervo M., Arnold R., Wells J.C., et al. Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and meta-analysis. Obes. Rev. 2011, 12(11):968-983.
284. Silvestri C., Di Marzo V. Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders. Expert Opin. Investig. Drugs 2012, 21(9):1309-1322.
285. Simon G.E., Ludman E.J., Linde J.A., et al. Association between obesity and depression in middle-aged women. Gen. Hosp. Psychiatry 2008, 30(1):32-39.
286. Simon G.E., Rohde P., Ludman E.J., et al. Association between change in depression and change in weight among women enrolled in weight loss treatment. Gen. Hosp. Psychiatry 2010, 32(6):583-589.
287. Skjelstad D.V., Malt U.F., Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J. Affect. Disord. 2010, 126(1-2):1-13.
288. Smoller J.W., Finn C.T. Family, twin, and adoption studies of bipolar disorder. Am. J. Med. Genet. C: Semin. Med. Genet. 2003, 123C(1):48-58.
289. Snyder H.R. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol. Bull. 2013, 139(1):81-132.
290. Sozeri-Varma G., Kalkan-Oguzhanoglu N., Efe M., Kiroglu Y., Duman T. Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression. Neuropsychiatr. Dis. Treat. 2013, 9:1053-1059.
291. Stefan N., Kantartzis K., Machann J., et al. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 2008, 168(15):1609-1616.
292. Steptoe A., Kunz-Ebrecht S.R., Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol. Med. 2003, 33(4):667-674.
293. Sterling P. Allostasis: a model of predictive regulation. Physiol. Behav. 2012, 106(1):5-15.
294. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosomal Med. 2011, 73(2):114-126.
295. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 2005, 10(10):900-919.
296. Strachan M.W., Deary I.J., Ewing F.M., Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997, 20(3):438-445.
297. Strakowski S.M., Adler C.M., Almeida J., et al. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord. 2012, 14(4):313-325.
298. Stranahan A.M., Norman E.D., Lee K., et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 2008, 18(11):1085-1088.
299. Strekalova T., Couch Y., Kholod N., et al. Update in the methodology of the chronic stress paradigm: internal control matters. Behav. Brain Funct. 2011, 7:9.
300. Stunkard A.J., Foch T.T., Hrubec Z. A twin study of human obesity. JAMA 1986, 256(1):51-54.
301. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 2000, 157(10):1552-1562.
302. 1H NMR spectroscopy and chemometrics. Anal. Chem. 2009, 81(23):9755-9763.
303. Swift D.L., Johannsen N.M., Lavie C.J., Earnest C.P., Church T.S. The role of exercise and physical activity in weight loss and maintenance. Prog. Cardiovasc. Dis. 2014, 56(4):441-447.
304. Tamashiro K.L., Sakai R.R., Shively C.A., Karatsoreos I.N., Reagan L.P. Chronic stress, metabolism, and metabolic syndrome. Stress 2011, 14(5):468-474.
305. Tanaka T., Ngwa J.S., van Rooij F.J., et al. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am. J. Clin. Nutr. 2013, 97(6):1395-1402.
306. Taylor V.H., MacQueen G.M. Cognitive dysfunction associated with metabolic syndrome. Obes. Rev. 2007, 8(5):409-418.
307. Teh A.L., Pan H., Chen L., et al. The effect of genotype and in utero environment on interindividual variation in neonate DNA methylomes. Genome Res. 2014, 24(7):1064-1074.
308. Thomas G., Khunti K., Curcin V., et al. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes. Metab. 2014, 16(4):317-325.
309. Thrush A.B., Dent R., McPherson R., Harper M.E. Implications of mitochondrial uncoupling in skeletal muscle in the development and treatment of obesity. FEBS J. 2013, 280(20):5015-5029.
310. Tobias D.K., Pan A., Jackson C.L., et al. Body-mass index and mortality among adults with incident type 2 diabetes. N. Engl. J. Med. 2014, 370(3):233-244.
311. Toups M.S., Myers A.K., Wisniewski S.R., et al. Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication. Psychosomal Med. 2013, 75(9):863-872.
312. Tremblay A., Chaput J.P. Obesity: the allostatic load of weight loss dieting. Physiol. Behav. 2012, 106(1):16-21.
313. Tryon M.S., DeCant R., Laugero K.D. Having your cake and eating it too: a habit of comfort food may link chronic social stress exposure and acute stress-induced cortisol hyporesponsiveness. Physiol. Behav. 2013, 114-115:32-37.
314. Uher R., Mors O., Hauser J., et al. Body weight as a predictor of antidepressant efficacy in the GENDEP project. J. Affect. Disord. 2009, 118(1-3):147-154.
315. Unger T.J., Calderon G.A., Bradley L.C., Sena-Esteves M., Rios M. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J. Neurosci. 2007, 27(52):14265-14274.
316. van de Giessen E., Celik F., Schweitzer D.H., van den Brink W., Booij J. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. J. Psychopharmacol. 2014, 28(9):866-873.
317. van Duinkerken E., Schoonheim M.M., Ijzerman R.G., et al. Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions. Diabetologia 2012, 55(4):1218-1220.
318. van Duinkerken E., Schoonheim M.M., Sanz-Arigita E.J., et al. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes 2012, 61(7):1814-1820.
319. van Loo H.M., de Jonge P., Romeijn J.W., Kessler R.C., Schoevers R.A. Data-driven subtypes of major depressive disorder: a systematic review. BMC Med. 2012, 10:156.
320. Vancampfort D., Correll C.U., Probst M., et al. A review of physical activity correlates in patients with bipolar disorder. J. Affect. Disord. 2013, 145(3):285-291.
321. Vancampfort D., Vansteelandt K., Correll C.U., et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am. J. Psychiatry 2013, 170(3):265-274.
322. Vannucchi G., Toni C., Maremmani I., Perugi G. Does obesity predict bipolarity in major depressive patients?. J. Affect. Disord. 2014, 155:118-122.
323. Vargas C., Lopez-Jaramillo C., Vieta E. A systematic literature review of resting state network-functional MRI in bipolar disorder. J. Affect. Disord. 2013, 150(3):727-735.
324. Vederine F.E., Wessa M., Leboyer M., Houenou J. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(8):1820-1826.
325. Veen G., Giltay E.J., DeRijk R.H., van Vliet I.M., van Pelt J., Zitman F.G. Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders. Metabolism 2009, 58(6):821-827.
326. Vernochet C., Kahn C.R. Mitochondria, obesity and aging. Aging (Albany, NY) 2012, 4(12):859-860.
327. Vogelzangs N., Beekman A.T., Boelhouwer I.G., et al. Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. J. Clin. Psychiatry 2011, 72(5):598-604.
328. Vogelzangs N., Duivis H.E., Beekman A.T., et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl. Psychiatry 2012, 2:e79.
329. Vogelzangs N., Kritchevsky S.B., Beekman A.T., et al. Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J. Clin. Psychiatry 2010, 71(4):391-399.
330. Volkow N.D., Wang G.J., Baler R.D. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn. Sci. 2011, 15(1):37-46.
331. Volkow N.D., Wang G.J., Fowler J.S., Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2008, 363(1507):3191-3200.
332. Vos T., Flaxman A.D., Naghavi M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2163-2196.
333. Vreeburg S.A., Hoogendijk W.J., van Pelt J., et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch. Gen. Psychiatry 2009, 66(6):617-626.
334. Wang-Sattler R., Yu Z., Herder C., et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol. Syst. Biol. 2012, 8:615.
335. Wang L., Anderson J.L., Dalton W.T., Wu T., Liu X., Zheng S. Maternal depressive symptoms and the risk of overweight in their children. Matern. Child Health J. 2013, 17(5):940-948.
336. Wang T.J., Larson M.G., Vasan R.S., et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 2011, 17(4):448-453.
337. Watson S., Gallagher P., Dougall D., et al. Childhood trauma in bipolar disorder. Aust. N. Z. J. Psychiatry 2013.
338. Werrij M.Q., Mulkens S., Hospers H.J., Jansen A. Overweight and obesity: the significance of a depressed mood. Patient Educ. Couns. 2006, 62(1):126-131.
339. Whiteford H.A., Harris M.G., McKeon G., et al. Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychol. Med. 2013, 43(8):1569-1585.
340. Whitmer R.A., Gunderson E.P., Barrett-Connor E., Quesenberry C.P., Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005, 330(7504):1360.
341. Wildman R.P., Muntner P., Reynolds K., et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch. Intern. Med. 2008, 168(15):1617-1624.
342. Wilhelm C.J., Choi D., Huckans M., Manthe L., Loftis J.M. Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression. Pharmacol. Biochem. Behav. 2013, 103(3):643-651.
343. Winham S.J., Biernacka J.M. Gene-environment interactions in genome-wide association studies: current approaches and new directions. J. Child Psychol. Psychiatry 2013, 54(10):1120-1134.
344. Wojcik W., Lee W., Colman I., Hardy R., Hotopf M. Foetal origins of depression? A systematic review and meta-analysis of low birth weight and later depression. Psychol. Med. 2013, 43(1):1-12.
345. Wong M.L., Kling M.A., Munson P.J., et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(1):325-330.
346. Woo J., Shin K.O., Park S.Y., Jang K.S., Kang S. Effects of exercise and diet change on cognition function and synaptic plasticity in high fat diet induced obese rats. Lipids Health Dis. 2013, 12:144.
347. Wu C.S., Nohr E.A., Bech B.H., Vestergaard M., Olsen J. Long-term health outcomes in children born to mothers with diabetes: a population-based cohort study. PLoS ONE 2012, 7(5):e36727.
348. Xia Q., Grant S.F. The genetics of human obesity. Ann. N. Y. Acad. Sci. 2013, 1281:178-190.
349. Xu B., Goulding E.H., Zang K., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 2003, 6(7):736-742.
350. Xu J., Dydak U., Harezlak J., et al. Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D (1)H MRS investigation. Psychiatry Res. 2013, 213(3):235-241.
351. Xu W.L., Atti A.R., Gatz M., Pedersen N.L., Johansson B., Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 2011, 76(18):1568-1574.
352. Yang N., Ginsburg G.S., Simmons L.A. Personalized medicine in women's obesity prevention and treatment: implications for research, policy and practice. Obes. Rev. 2013, 14(2):145-161.
353. Yanovski S.Z., Yanovski J.A. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014, 311(1):74-86.
354. Yim C.Y., Soczynska J.K., Kennedy S.H., Woldeyohannes H.O., Brietzke E., McIntyre R.S. The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. Eur. Psychiatry 2012, 27(3):223-228.
355. Zagrebelsky M., Korte M. Form follows function: BDNF and its involvement in sculpting the function and structure of synapses. Neuropharmacology 2014, 76(Pt C):628-638.
356. Zeman M., Jirak R., Jachymova M., Vecka M., Tvrzicka E., Zak A. Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women. Neuroendocrinol Lett. 2009, 30(3):387-395.
357. Zhao G., Ford E.S., Dhingra S., Li C., Strine T.W., Mokdad A.H. Depression and anxiety among US adults: associations with body mass index. Int. J. Obes. (Lond.) 2009, 33(2):257-266.
358. Zheng P., Wang Y., Chen L., et al. Identification and validation of urinary metabolite biomarkers for major depressive disorder. Mol. Cell Proteomics 2013, 12(1):207-214.
359. Zhou J.X., Li H.C., Bai X.J., et al. Functional Val66Met polymorphism of brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects. Behav. Brain Funct. 2013, 9:34.
360. Zupancic M.L., Mahajan A. Leptin as a neuroactive agent. Psychosomal Med. 2011, 73(5):407-414.